{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:47:35Z","timestamp":1794271655728,"version":"4.9.0"},"reference-count":178,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T00:00:00Z","timestamp":1607385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T00:00:00Z","timestamp":1607385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1038\/s41574-020-00443-4","type":"journal-article","created":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T14:04:38Z","timestamp":1607436278000},"page":"150-161","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":611,"title":["Type 1 diabetes mellitus as a disease of the \u03b2-cell (do not blame the immune system?)"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3110-7391","authenticated-orcid":false,"given":"Bart O.","family":"Roep","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Thomaidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"van Tienhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Zaldumbide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,8]]},"reference":[{"key":"443_CR1","first-page":"95","volume":"205","author":"W Gepts","year":"1976","unstructured":"Gepts, W. Islet changes suggesting a possible immune aetiology of human diabetes mellitus. Acta Endocrinol. Suppl. 205, 95\u2013106 (1976).","journal-title":"Acta Endocrinol. Suppl."},{"key":"443_CR2","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1056\/NEJM198508083130604","volume":"313","author":"GF Bottazzo","year":"1985","unstructured":"Bottazzo, G. F. et al. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N. Engl. J. Med. 313, 353\u2013360 (1985).","journal-title":"N. Engl. J. Med."},{"key":"443_CR3","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00125-003-1089-5","volume":"46","author":"BO Roep","year":"2003","unstructured":"Roep, B. O. The role of T-cells in the pathogenesis of type 1 diabetes: from cause to cure. Diabetologia 46, 305\u2013321 (2003).","journal-title":"Diabetologia"},{"key":"443_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrendo.2009.21","volume":"5","author":"DL Eizirik","year":"2009","unstructured":"Eizirik, D. L., Colli, M. L. & Ortis, F. The role of inflammation in insulitis and \u03b2-cell loss in type 1 diabetes. Nat. Rev. Endocrinol. 5, 219\u2013226 (2009).","journal-title":"Nat. Rev. Endocrinol."},{"key":"443_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.coi.2016.09.007","volume":"43","author":"BO Roep","year":"2016","unstructured":"Roep, B. O., Kracht, M. J., van Lummel, M. & Zaldumbide, A. A roadmap of the generation of neoantigens as targets of the immune system in type 1 diabetes. Curr. Opin. Immunol. 43, 67\u201373 (2016).","journal-title":"Curr. Opin. Immunol."},{"key":"443_CR6","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1007\/s00125-020-05176-7","volume":"63","author":"R Mallone","year":"2020","unstructured":"Mallone, R. & Eizirik, D. L. Presumption of innocence for beta cells: why are they vulnerable autoimmune targets in type 1 diabetes? Diabetologia 63, 1999\u20132006 (2020).","journal-title":"Diabetologia"},{"key":"443_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1084\/jem.20111187","volume":"209","author":"KT Coppieters","year":"2012","unstructured":"Coppieters, K. T. et al. Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. J. Exp. Med. 209, 51\u201360 (2012).","journal-title":"J. Exp. Med."},{"key":"443_CR8","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1007\/s00125-020-05115-6","volume":"63","author":"P Leete","year":"2020","unstructured":"Leete, P. et al. Studies of insulin and proinsulin in pancreas and serum support the existence of aetiopathological endotypes of type 1 diabetes associated with age at diagnosis. Diabetologia 63, 1258\u20131267 (2020).","journal-title":"Diabetologia"},{"key":"443_CR9","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.2337\/dc18-0465","volume":"41","author":"BM Shields","year":"2018","unstructured":"Shields, B. M. et al. C-peptide decline in type 1 diabetes has two phases: an initial exponential fall and a subsequent stable phase. Diabetes Care 41, 1486\u20131492 (2018).","journal-title":"Diabetes Care"},{"key":"443_CR10","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/S0140-6736(74)91201-X","volume":"2","author":"J Nerup","year":"1974","unstructured":"Nerup, J. et al. HL-A antigens and diabetes mellitus. Lancet 2, 864\u2013866 (1974).","journal-title":"Lancet"},{"key":"443_CR11","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/ng.381","volume":"41","author":"JC Barrett","year":"2009","unstructured":"Barrett, J. C. et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat. Genet. 41, 703\u2013707 (2009).","journal-title":"Nat. Genet."},{"key":"443_CR12","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.4049\/jimmunol.1501282","volume":"196","author":"M van Lummel","year":"2016","unstructured":"van Lummel, M. et al. Dendritic cells guide islet autoimmunity through a restricted and uniquely processed peptidome presented by high-risk HLA-DR. J. Immunol. 196, 3253\u20133263 (2016).","journal-title":"J. Immunol."},{"key":"443_CR13","doi-asserted-by":"publisher","first-page":"732","DOI":"10.2337\/db15-1031","volume":"65","author":"M van Lummel","year":"2016","unstructured":"van Lummel, M. et al. Discovery of a selective islet peptidome presented by the highest-risk HLA-DQ8trans molecule. Diabetes 65, 732\u2013741 (2016).","journal-title":"Diabetes"},{"key":"443_CR14","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/ng0397-293","volume":"15","author":"A Pugliese","year":"1997","unstructured":"Pugliese, A. et al. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat. Genet. 15, 293\u2013297 (1997).","journal-title":"Nat. Genet."},{"key":"443_CR15","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/ng0397-289","volume":"15","author":"P Vafiadis","year":"1997","unstructured":"Vafiadis, P. et al. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat. Genet. 15, 289\u2013292 (1997).","journal-title":"Nat. Genet."},{"key":"443_CR16","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/ng1323","volume":"36","author":"N Bottini","year":"2004","unstructured":"Bottini, N. et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat. Genet. 36, 337\u2013338 (2004).","journal-title":"Nat. Genet."},{"key":"443_CR17","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1086\/429843","volume":"76","author":"A Vella","year":"2005","unstructured":"Vella, A. et al. Localization of a type 1 diabetes locus in the IL2RA\/CD25 region by use of tag single-nucleotide polymorphisms. Am. J. Hum. Genet. 76, 773\u2013779 (2005).","journal-title":"Am. J. Hum. Genet."},{"key":"443_CR18","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1034\/j.1399-0039.2002.590202.x","volume":"59","author":"JA Gebe","year":"2002","unstructured":"Gebe, J. A., Swanson, E. & Kwok, W. W. HLA class II peptide-binding and autoimmunity. Tissue Antigens 59, 78\u201387 (2002).","journal-title":"Tissue Antigens"},{"key":"443_CR19","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/S0140-6736(74)90140-8","volume":"2","author":"GF Bottazzo","year":"1974","unstructured":"Bottazzo, G. F., Florin-Christensen, A. & Doniach, D. Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 2, 1279\u20131282 (1974).","journal-title":"Lancet"},{"key":"443_CR20","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1007\/s00125-017-4284-5","volume":"60","author":"SJ Bloem","year":"2017","unstructured":"Bloem, S. J. & Roep, B. O. The elusive role of B lymphocytes and islet autoantibodies in (human) type 1 diabetes. Diabetologia 60, 1185\u20131189 (2017).","journal-title":"Diabetologia"},{"key":"443_CR21","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1365-2249.2008.03860.x","volume":"155","author":"A Willcox","year":"2009","unstructured":"Willcox, A., Richardson, S. J., Bone, A. J., Foulis, A. K. & Morgan, N. G. Analysis of islet inflammation in human type 1 diabetes. Clin. Exp. Immunol. 155, 173\u2013181 (2009).","journal-title":"Clin. Exp. Immunol."},{"key":"443_CR22","doi-asserted-by":"publisher","first-page":"719","DOI":"10.2337\/db15-0779","volume":"65","author":"M Campbell-Thompson","year":"2015","unstructured":"Campbell-Thompson, M. et al. Insulitis and \u03b2-cell mass in the natural history of type 1 diabetes. Diabetes 65, 719\u2013731 (2015).","journal-title":"Diabetes"},{"key":"443_CR23","doi-asserted-by":"publisher","first-page":"619","DOI":"10.2337\/diab.14.10.619","volume":"14","author":"W Gepts","year":"1965","unstructured":"Gepts, W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14, 619\u2013663 (1965).","journal-title":"Diabetes"},{"key":"443_CR24","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s00125-008-1237-z","volume":"52","author":"JH Velthuis","year":"2009","unstructured":"Velthuis, J. H. et al. Accumulation of autoreactive effector T cells and allo-specific regulatory T cells in the pancreas allograft of a type 1 diabetic recipient. Diabetologia 52, 494\u2013503 (2009).","journal-title":"Diabetologia"},{"key":"443_CR25","doi-asserted-by":"publisher","first-page":"722","DOI":"10.2337\/db16-1025","volume":"66","author":"AW Michels","year":"2017","unstructured":"Michels, A. W. et al. Islet-derived CD4 T cells targeting proinsulin in human autoimmune diabetes. Diabetes 66, 722\u2013734 (2017).","journal-title":"Diabetes"},{"key":"443_CR26","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1038\/nm.4203","volume":"22","author":"JA Babon","year":"2016","unstructured":"Babon, J. A. et al. Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes. Nat. Med. 22, 1482\u20131487 (2016).","journal-title":"Nat. Med."},{"key":"443_CR27","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/0140-6736(91)93127-U","volume":"337","author":"BO Roep","year":"1991","unstructured":"Roep, B. O. et al. T-cell reactivity to 38 kD insulin-secretory-granule protein in patients with recent-onset type 1 diabetes. Lancet 337, 1439\u20131441 (1991).","journal-title":"Lancet"},{"key":"443_CR28","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/345632a0","volume":"345","author":"BO Roep","year":"1990","unstructured":"Roep, B. O., Arden, S. D., De Vries, R. R. P. & Hutton, J. C. T-cell clones from a type-1 diabetes patient respond to insulin secretory granule proteins. Nature 345, 632\u2013634 (1990).","journal-title":"Nature"},{"key":"443_CR29","doi-asserted-by":"publisher","first-page":"10954","DOI":"10.1073\/pnas.1710415114","volume":"114","author":"S Tan","year":"2017","unstructured":"Tan, S. et al. Type 1 diabetes induction in humanized mice. Proc. Natl Acad. Sci. USA 114, 10954\u201310959 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"443_CR30","first-page":"3390","volume":"118","author":"A Skowera","year":"2008","unstructured":"Skowera, A. et al. CTLs are targeted to kill \u03b2 cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope. J. Clin. Invest. 118, 3390\u20133402 (2008).","journal-title":"J. Clin. Invest."},{"key":"443_CR31","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/nm.4289","volume":"23","author":"MJ Kracht","year":"2017","unstructured":"Kracht, M. J. et al. Autoimmunity against a defective ribosomal insulin gene product in type 1 diabetes. Nat. Med. 23, 501\u2013507 (2017).","journal-title":"Nat. Med."},{"key":"443_CR32","doi-asserted-by":"publisher","first-page":"eaao4013","DOI":"10.1126\/sciimmunol.aao4013","volume":"3","author":"S Culina","year":"2018","unstructured":"Culina, S. et al. Islet-reactive CD8(+) T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors. Sci. Immunol. 3, eaao4013 (2018).","journal-title":"Sci. Immunol."},{"key":"443_CR33","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.ajpath.2016.11.002","volume":"187","author":"E Kuric","year":"2017","unstructured":"Kuric, E. et al. Demonstration of tissue resident memory CD8 T cells in insulitic lesions in adult patients with recent-onset type 1 diabetes. Am. J. Pathol. 187, 581\u2013588 (2017).","journal-title":"Am. J. Pathol."},{"key":"443_CR34","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.2337\/db09-0503","volume":"59","author":"TI Tree","year":"2010","unstructured":"Tree, T. I. et al. Naturally arising human CD4 T-cells that recognize islet autoantigens and secrete interleukin-10 regulate proinflammatory T-cell responses via linked suppression. Diabetes 59, 1451\u20131460 (2010).","journal-title":"Diabetes"},{"key":"443_CR35","doi-asserted-by":"publisher","first-page":"92","DOI":"10.2337\/diabetes.54.1.92","volume":"54","author":"S Lindley","year":"2005","unstructured":"Lindley, S. et al. Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. Diabetes 54, 92\u201399 (2005).","journal-title":"Diabetes"},{"key":"443_CR36","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/nri2889","volume":"10","author":"JH Buckner","year":"2010","unstructured":"Buckner, J. H. Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases. Nat. Rev. Immunol. 10, 849\u2013859 (2010).","journal-title":"Nat. Rev. Immunol."},{"key":"443_CR37","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.2337\/db06-0065","volume":"55","author":"Q Ouyang","year":"2006","unstructured":"Ouyang, Q. et al. Recognition of HLA class I-restricted \u03b2-cell epitopes in type 1 diabetes. Diabetes 55, 3068\u20133074 (2006).","journal-title":"Diabetes"},{"key":"443_CR38","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1365-2249.2012.04635.x","volume":"170","author":"JR Abreu","year":"2012","unstructured":"Abreu, J. R. et al. CD8 T cell autoreactivity to preproinsulin epitopes with very low human leucocyte antigen class I binding affinity. Clin. Exp. Immunol. 170, 57\u201365 (2012).","journal-title":"Clin. Exp. Immunol."},{"key":"443_CR39","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.2337\/db09-1486","volume":"59","author":"JH Velthuis","year":"2010","unstructured":"Velthuis, J. H. et al. Simultaneous detection of circulating autoreactive CD8+ T-cells specific for different islet cell-associated epitopes using combinatorial MHC multimers. Diabetes 59, 1721\u20131730 (2010).","journal-title":"Diabetes"},{"key":"443_CR40","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jaut.2011.05.012","volume":"37","author":"WW Unger","year":"2011","unstructured":"Unger, W. W. et al. Discovery of low-affinity preproinsulin epitopes and detection of autoreactive CD8 T-cells using combinatorial MHC multimers. J. Autoimmun. 37, 151\u2013159 (2011).","journal-title":"J. Autoimmun."},{"key":"443_CR41","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/ni.3271","volume":"16","author":"DX Beringer","year":"2015","unstructured":"Beringer, D. X. et al. T cell receptor reversed polarity recognition of a self-antigen major histocompatibility complex. Nat. Immunol. 16, 1153\u20131161 (2015).","journal-title":"Nat. Immunol."},{"key":"443_CR42","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/ni.2206","volume":"13","author":"AM Bulek","year":"2012","unstructured":"Bulek, A. M. et al. Structural basis for the killing of human beta cells by CD8(+) T cells in type 1 diabetes. Nat. Immunol. 13, 283\u2013289 (2012).","journal-title":"Nat. Immunol."},{"key":"443_CR43","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1084\/jem.20111485","volume":"209","author":"DA Schubert","year":"2012","unstructured":"Schubert, D. A. et al. Self-reactive human CD4 T cell clones form unusual immunological synapses. J. Exp. Med. 209, 335\u2013352 (2012).","journal-title":"J. Exp. Med."},{"key":"443_CR44","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.immuni.2005.09.009","volume":"23","author":"MJ Nicholson","year":"2005","unstructured":"Nicholson, M. J., Hahn, M. & Wucherpfennig, K. W. Unusual features of self-peptide\/MHC binding by autoimmune T cell receptors. Immunity 23, 351\u2013360 (2005).","journal-title":"Immunity"},{"key":"443_CR45","doi-asserted-by":"publisher","first-page":"17414","DOI":"10.1073\/pnas.0605136103","volume":"103","author":"C Beeton","year":"2006","unstructured":"Beeton, C. et al. Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases. Proc. Natl Acad. Sci. USA 103, 17414\u201317419 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"443_CR46","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.2337\/dbi18-0002","volume":"67","author":"AM Stamatouli","year":"2018","unstructured":"Stamatouli, A. M. et al. Collateral damage: insulin-dependent diabetes induced with checkpoint inhibitors. Diabetes 67, 1471\u20131480 (2018).","journal-title":"Diabetes"},{"key":"443_CR47","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1530\/EJE-19-0291","volume":"181","author":"JMK de Filette","year":"2019","unstructured":"de Filette, J. M. K. et al. Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review. Eur. J. Endocrinol. 181, 363\u2013374 (2019).","journal-title":"Eur. J. Endocrinol."},{"key":"443_CR48","doi-asserted-by":"publisher","first-page":"5499","DOI":"10.1210\/jc.2019-00423","volume":"104","author":"VHM Tsang","year":"2019","unstructured":"Tsang, V. H. M. et al. Checkpoint inhibitor-associated autoimmune diabetes is distinct from type 1 diabetes. J. Clin. Endocrinol. Metab. 104, 5499\u20135506 (2019).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"443_CR49","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.2337\/db15-1615","volume":"65","author":"P Leete","year":"2016","unstructured":"Leete, P. et al. Differential insulitic profiles determine the extent of \u03b2-cell destruction and the age at onset of type 1 diabetes. Diabetes 65, 1362\u20131369 (2016).","journal-title":"Diabetes"},{"key":"443_CR50","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2337\/dc19-0880","volume":"43","author":"M Battaglia","year":"2020","unstructured":"Battaglia, M. et al. Introducing the endotype concept to address the challenge of disease heterogeneity in type 1 diabetes. Diabetes Care 43, 5\u201312 (2020).","journal-title":"Diabetes Care"},{"key":"443_CR51","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00125-019-05032-3","volume":"63","author":"LA Claessens","year":"2019","unstructured":"Claessens, L. A. et al. Clinical and genetic correlates of islet-autoimmune signatures in juvenile-onset type 1 diabetes. Diabetologia 63, 351\u2013361 (2019).","journal-title":"Diabetologia"},{"key":"443_CR52","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/0140-6736(93)91148-F","volume":"341","author":"EF Lampeter","year":"1993","unstructured":"Lampeter, E. F. et al. Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation. Lancet 341, 1243\u20131244 (1993).","journal-title":"Lancet"},{"key":"443_CR53","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s001250050134","volume":"37","author":"EF Lampeter","year":"1994","unstructured":"Lampeter, E. F. et al. Inflammatory islet damage in patients bearing HLA-Dr 3 and\/or Dr 4 haplotypes does not lead to islet autoimmunity. Diabetologia 37, 471\u2013475 (1994).","journal-title":"Diabetologia"},{"key":"443_CR54","first-page":"132","volume":"53","author":"R Sibley","year":"1985","unstructured":"Sibley, R., Sutherland, D. E. R., Goetz, F. & Michael, A. F. Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. Lab. Invest. 53, 132\u2013144 (1985).","journal-title":"Lab. Invest."},{"key":"443_CR55","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3389\/fimmu.2017.00167","volume":"8","author":"KC Malmegrim","year":"2017","unstructured":"Malmegrim, K. C. et al. Immunological balance is associated with clinical outcome after autologous hematopoietic stem cell transplantation in type 1 diabetes. Front. Immunol. 8, 167 (2017).","journal-title":"Front. Immunol."},{"key":"443_CR56","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.2337\/db09-0160","volume":"58","author":"R Hilbrands","year":"2009","unstructured":"Hilbrands, R. et al. Differences in baseline lymphocyte counts and autoreactivity are associated with differences in outcome of islet cell transplantation in type 1 diabetic patients. Diabetes 58, 2267\u20132276 (2009).","journal-title":"Diabetes"},{"key":"443_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002435","volume":"3","author":"VA Huurman","year":"2008","unstructured":"Huurman, V. A. et al. Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation. PLoS ONE 3, e2435 (2008).","journal-title":"PLoS ONE"},{"key":"443_CR58","doi-asserted-by":"publisher","first-page":"18425","DOI":"10.1073\/pnas.0508621102","volume":"102","author":"GG Pinkse","year":"2005","unstructured":"Pinkse, G. G. et al. Autoreactive CD8 T cells associated with \u03b2 cell destruction in type 1 diabetes. Proc. Natl Acad. Sci. USA 102, 18425\u201318430 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"443_CR59","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S2213-8587(18)30109-8","volume":"7","author":"BO Roep","year":"2019","unstructured":"Roep, B. O., Wheeler, D. C. S. & Peakman, M. Antigen-based immune modulation therapy for type 1 diabetes: the era of precision medicine. Lancet Diabetes Endocrinol. 7, 65\u201374 (2019).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"443_CR60","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/S2213-8587(18)30112-8","volume":"7","author":"MA Atkinson","year":"2019","unstructured":"Atkinson, M. A., Roep, B. O., Posgai, A., Wheeler, D. C. S. & Peakman, M. The challenge of modulating \u03b2-cell autoimmunity in type 1 diabetes. Lancet Diabetes Endocrinol. 7, 52\u201364 (2019).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"443_CR61","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/MED.0b013e32835edb89","volume":"20","author":"O Skog","year":"2013","unstructured":"Skog, O., Korsgren, S., Melhus, A. & Korsgren, O. Revisiting the notion of type 1 diabetes being a T-cell-mediated autoimmune disease. Curr. Opin. Endocrinol. Diabetes Obes. 20, 118\u2013123 (2013).","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"443_CR62","doi-asserted-by":"publisher","first-page":"278","DOI":"10.2337\/diab.44.3.278","volume":"44","author":"BO Roep","year":"1995","unstructured":"Roep, B. O. et al. T-cell reactivity to \u03b2-cell membrane antigens associated with \u03b2-cell destruction in IDDM. Diabetes 44, 278\u2013283 (1995).","journal-title":"Diabetes"},{"key":"443_CR63","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1006\/jaut.1999.0312","volume":"13","author":"BO Roep","year":"1999","unstructured":"Roep, B. O. et al. Autoreactive T cell responses in insulin-dependent (type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays. J. Autoimmun. 13, 267\u2013282 (1999).","journal-title":"J. Autoimmun."},{"key":"443_CR64","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2337\/db09-0694","volume":"59","author":"SA Long","year":"2010","unstructured":"Long, S. A. et al. Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects. Diabetes 59, 407\u2013415 (2010).","journal-title":"Diabetes"},{"key":"443_CR65","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/cei.12687","volume":"182","author":"VB Gibson","year":"2015","unstructured":"Gibson, V. B. et al. Proinsulin multi-peptide immunotherapy induces antigen-specific regulatory T cells and limits autoimmunity in a humanized model. Clin. Exp. Immunol. 182, 251\u2013260 (2015).","journal-title":"Clin. Exp. Immunol."},{"key":"443_CR66","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1056\/NEJMoa0804328","volume":"359","author":"J Ludvigsson","year":"2008","unstructured":"Ludvigsson, J. et al. GAD treatment and insulin secretion in recent-onset type 1 diabetes. N. Engl. J. Med. 359, 1909\u20131920 (2008).","journal-title":"N. Engl. J. Med."},{"key":"443_CR67","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/dmrr.691","volume":"23","author":"VA Huurman","year":"2007","unstructured":"Huurman, V. A., Decochez, K., Mathieu, C., Cohen, I. R. & Roep, B. O. Therapy with the hsp60 peptide DiaPep277 in C-peptide positive type 1 diabetes patients. Diabetes Metab. Res. Rev. 23, 269\u2013275 (2007).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"443_CR68","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/j.1365-2249.2008.03814.x","volume":"155","author":"SL Thrower","year":"2009","unstructured":"Thrower, S. L. et al. Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man phase I safety study. Clin. Exp. Immunol. 155, 156\u2013165 (2009).","journal-title":"Clin. Exp. Immunol."},{"key":"443_CR69","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.1365-2559.1988.tb01968.x","volume":"12","author":"AK Foulis","year":"1988","unstructured":"Foulis, A. K., Jackson, R. & Farquharson, M. A. The pancreas in idiopathic Addison\u2019s disease\u2013a search for a prediabetic pancreas. Histopathology 12, 481\u2013490 (1988).","journal-title":"Histopathology"},{"key":"443_CR70","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.2337\/db07-0416","volume":"56","author":"P In\u2019t Veld","year":"2007","unstructured":"In\u2019t Veld, P. et al. Screening for insulitis in adult autoantibody-positive organ donors. Diabetes 56, 2400\u20132404 (2007).","journal-title":"Diabetes"},{"key":"443_CR71","doi-asserted-by":"publisher","first-page":"5967","DOI":"10.4049\/jimmunol.172.10.5967","volume":"172","author":"NA Danke","year":"2004","unstructured":"Danke, N. A., Koelle, D. M., Yee, C., Beheray, S. & Kwok, W. W. Autoreactive T cells in healthy individuals. J. Immunol. 172, 5967\u20135972 (2004).","journal-title":"J. Immunol."},{"key":"443_CR72","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1464-5491.1986.tb00722.x","volume":"3","author":"GF Bottazzo","year":"1986","unstructured":"Bottazzo, G. F. Lawrence lecture. Death of a beta cell: homicide or suicide? Diabet. Med. 3, 119\u2013130 (1986).","journal-title":"Diabet. Med."},{"key":"443_CR73","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1001\/jama.2012.15008","volume":"308","author":"M Campbell-Thompson","year":"2012","unstructured":"Campbell-Thompson, M., Wasserfall, C., Montgomery, E. L., Atkinson, M. A. & Kaddis, J. S. Pancreas organ weight in individuals with disease-associated autoantibodies at risk for type 1 diabetes. JAMA 308, 2337\u20132339 (2012).","journal-title":"JAMA"},{"key":"443_CR74","doi-asserted-by":"publisher","first-page":"5115","DOI":"10.1073\/pnas.0700442104","volume":"104","author":"F Dotta","year":"2007","unstructured":"Dotta, F. et al. Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc. Natl Acad. Sci. USA 104, 5115\u20135120 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"443_CR75","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.2337\/db14-1370","volume":"64","author":"L Krogvold","year":"2015","unstructured":"Krogvold, L. et al. Detection of a low-grade enteroviral infection in the islets of Langerhans of living patients newly diagnosed with type 1 diabetes. Diabetes 64, 1682\u20131687 (2015).","journal-title":"Diabetes"},{"key":"443_CR76","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1038\/s41591-019-0667-0","volume":"25","author":"K Vehik","year":"2019","unstructured":"Vehik, K. et al. Prospective virome analyses in young children at increased genetic risk for type 1 diabetes. Nat. Med. 25, 1865\u20131872 (2019).","journal-title":"Nat. Med."},{"key":"443_CR77","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1007\/s00125-018-4704-1","volume":"61","author":"E Ifie","year":"2018","unstructured":"Ifie, E. et al. Unexpected subcellular distribution of a specific isoform of the Coxsackie and adenovirus receptor, CAR-SIV, in human pancreatic beta cells. Diabetologia 61, 2344\u20132355 (2018).","journal-title":"Diabetologia"},{"key":"443_CR78","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1038\/s41591-019-0689-7","volume":"25","author":"BO Roep","year":"2019","unstructured":"Roep, B. O. A viral link for type 1 diabetes. Nat. Med. 25, 1816\u20131818 (2019).","journal-title":"Nat. Med."},{"key":"443_CR79","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.2337\/diabetes.49.8.1319","volume":"49","author":"MC Honeyman","year":"2000","unstructured":"Honeyman, M. C. et al. Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes. Diabetes 49, 1319\u20131324 (2000).","journal-title":"Diabetes"},{"key":"443_CR80","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1001\/jamapediatrics.2018.4578","volume":"173","author":"KP Perrett","year":"2019","unstructured":"Perrett, K. P., Jachno, K., Nolan, T. M. & Harrison, L. C. Association of rotavirus vaccination with the incidence of type 1 diabetes in children. JAMA Pediatr. 173, 280\u2013282 (2019).","journal-title":"JAMA Pediatr."},{"key":"443_CR81","doi-asserted-by":"publisher","first-page":"3988","DOI":"10.1073\/pnas.071050898","volume":"98","author":"HS Hiemstra","year":"2001","unstructured":"Hiemstra, H. S. et al. Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase. Proc. Natl Acad. Sci. USA 98, 3988\u20133991 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"443_CR82","doi-asserted-by":"publisher","first-page":"995","DOI":"10.3390\/ijms19040995","volume":"19","author":"H Han","year":"2018","unstructured":"Han, H. et al. Gut microbiota and type 1 diabetes. Int. J. Mol. Sci. 19, 995\u20131006 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"443_CR83","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/19490976.2015.1134082","volume":"7","author":"DJ Morrison","year":"2016","unstructured":"Morrison, D. J. & Preston, T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes 7, 189\u2013200 (2016).","journal-title":"Gut Microbes"},{"key":"443_CR84","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3109\/08820139.2015.1122613","volume":"45","author":"M Asarat","year":"2016","unstructured":"Asarat, M., Apostolopoulos, V., Vasiljevic, T. & Donkor, O. Short-Chain fatty acids regulate cytokines and Th17\/Treg cells in human peripheral blood mononuclear cells in vitro. Immunol. Invest. 45, 205\u2013222 (2016).","journal-title":"Immunol. Invest."},{"key":"443_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15099-w","volume":"7","author":"C Nastasi","year":"2017","unstructured":"Nastasi, C. et al. Butyrate and propionate inhibit antigen-specific CD8(+) T cell activation by suppressing IL-12 production by antigen-presenting cells. Sci. Rep. 7, 14516 (2017).","journal-title":"Sci. Rep."},{"key":"443_CR86","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.immuni.2015.07.013","volume":"43","author":"J Sun","year":"2015","unstructured":"Sun, J. et al. Pancreatic \u03b2-cells limit autoimmune diabetes via an immunoregulatory antimicrobial peptide expressed under the influence of the gut microbiota. Immunity 43, 304\u2013317 (2015).","journal-title":"Immunity"},{"key":"443_CR87","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.cmet.2018.06.012","volume":"28","author":"M Miani","year":"2018","unstructured":"Miani, M. et al. Gut microbiota-stimulated innate lymphoid cells support \u03b2-defensin 14 expression in pancreatic endocrine cells, preventing autoimmune diabetes. Cell Metab. 28, 557\u2013572 e6 (2018).","journal-title":"Cell Metab."},{"key":"443_CR88","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/dom.13529","volume":"21","author":"A Pingitore","year":"2019","unstructured":"Pingitore, A. et al. Short chain fatty acids stimulate insulin secretion and reduce apoptosis in mouse and human islets in vitro: role of free fatty acid receptor 2. Diabetes Obes. Metab. 21, 330\u2013339 (2019).","journal-title":"Diabetes Obes. Metab."},{"key":"443_CR89","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00125-019-05073-8","volume":"63","author":"PF de Groot","year":"2020","unstructured":"de Groot, P. F. et al. Oral butyrate does not affect innate immunity and islet autoimmunity in individuals with longstanding type 1 diabetes: a randomised controlled trial. Diabetologia 63, 597\u2013610 (2020).","journal-title":"Diabetologia"},{"key":"443_CR90","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07019-x","volume":"9","author":"LBS Hansen","year":"2018","unstructured":"Hansen, L. B. S. et al. A low-gluten diet induces changes in the intestinal microbiome of healthy Danish adults. Nat. Commun. 9, 4630 (2018).","journal-title":"Nat. Commun."},{"key":"443_CR91","doi-asserted-by":"publisher","first-page":"k3547","DOI":"10.1136\/bmj.k3547","volume":"362","author":"JC Antvorskov","year":"2018","unstructured":"Antvorskov, J. C. et al. Association between maternal gluten intake and type 1 diabetes in offspring: national prospective cohort study in Denmark. BMJ 362, k3547 (2018).","journal-title":"BMJ"},{"key":"443_CR92","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.2337\/diabetes.53.7.1884","volume":"53","author":"BJ Barratt","year":"2004","unstructured":"Barratt, B. J. et al. Remapping the insulin gene\/IDDM2 locus in type 1 diabetes. Diabetes 53, 1884\u20131889 (2004).","journal-title":"Diabetes"},{"key":"443_CR93","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00125-005-0042-1","volume":"49","author":"LB Nielsen","year":"2006","unstructured":"Nielsen, L. B. et al. Impact of IDDM2 on disease pathogenesis and progression in children with newly diagnosed type 1 diabetes: reduced insulin antibody titres and preserved beta cell function. Diabetologia 49, 71\u201374 (2006).","journal-title":"Diabetologia"},{"key":"443_CR94","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/gene.2009.108","volume":"11","author":"I Durinovic-Bello","year":"2010","unstructured":"Durinovic-Bello, I. et al. Insulin gene VNTR genotype associates with frequency and phenotype of the autoimmune response to proinsulin. Genes Immun. 11, 188\u2013193 (2010).","journal-title":"Genes Immun."},{"issue":"Suppl. 2","key":"443_CR95","doi-asserted-by":"publisher","first-page":"18","DOI":"10.2337\/diabetes.54.suppl_2.S18","volume":"54","author":"I Durinovic-Bello","year":"2005","unstructured":"Durinovic-Bello, I. et al. Class III alleles at the insulin VNTR polymorphism are associated with regulatory T-cell responses to proinsulin epitopes in HLA-DR4, DQ8 individuals. Diabetes 54 (Suppl. 2), 18\u201324 (2005).","journal-title":"Diabetes"},{"key":"443_CR96","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1006\/jaut.1996.0057","volume":"9","author":"ST Bennett","year":"1996","unstructured":"Bennett, S. T. et al. IDDM2-VNTR-encoded susceptibility to type 1 diabetes: dominant protection and parental transmission of alleles of the insulin gene-linked minisatellite locus. J. Autoimmun. 9, 415\u2013421 (1996).","journal-title":"J. Autoimmun."},{"key":"443_CR97","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1006\/jaut.1996.0054","volume":"9","author":"P Vafiadis","year":"1996","unstructured":"Vafiadis, P. et al. Imprinted and genotype-specific expression of genes at the IDDM2 locus in pancreas and leucocytes. J. Autoimmun. 9, 397\u2013403 (1996).","journal-title":"J. Autoimmun."},{"key":"443_CR98","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1042\/BST0360328","volume":"36","author":"C Gysemans","year":"2008","unstructured":"Gysemans, C., Callewaert, H., Overbergh, L. & Mathieu, C. Cytokine signalling in the \u03b2-cell: a dual role for IFN\u03b3. Biochem. Soc. Trans. 36, 328\u2013333 (2008).","journal-title":"Biochem. Soc. Trans."},{"key":"443_CR99","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002552","volume":"8","author":"DL Eizirik","year":"2012","unstructured":"Eizirik, D. L. et al. The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines. PLoS Genet. 8, e1002552 (2012).","journal-title":"PLoS Genet."},{"key":"443_CR100","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/371130a0","volume":"371","author":"JL Davies","year":"1994","unstructured":"Davies, J. L. et al. A genome-wide search for human type 1 diabetes susceptibility genes. Nature 371, 130\u2013136 (1994).","journal-title":"Nature"},{"key":"443_CR101","doi-asserted-by":"publisher","first-page":"679","DOI":"10.2337\/db09-1378","volume":"59","author":"E Ferrannini","year":"2010","unstructured":"Ferrannini, E. et al. Progression to diabetes in relatives of type 1 diabetic patients: mechanisms and mode of onset. Diabetes 59, 679\u2013685 (2010).","journal-title":"Diabetes"},{"key":"443_CR102","doi-asserted-by":"publisher","first-page":"4179","DOI":"10.2337\/db13-0656","volume":"62","author":"JM Sosenko","year":"2013","unstructured":"Sosenko, J. M. et al. The acceleration of the loss of the first-phase insulin response during the progression to type 1 diabetes in diabetes prevention trial-type 1 participants. Diabetes 62, 4179\u20134183 (2013).","journal-title":"Diabetes"},{"key":"443_CR103","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1007\/s00125-012-2604-3","volume":"55","author":"I Marhfour","year":"2012","unstructured":"Marhfour, I. et al. Expression of endoplasmic reticulum stress markers in the islets of patients with type 1 diabetes. Diabetologia 55, 2417\u20132420 (2012).","journal-title":"Diabetologia"},{"key":"443_CR104","doi-asserted-by":"publisher","first-page":"670","DOI":"10.2337\/db19-0984","volume":"69","author":"S Thomaidou","year":"2020","unstructured":"Thomaidou, S. et al. \u03b2-Cell stress shapes CTL immune recognition of preproinsulin signal peptide by posttranscriptional regulation of endoplasmic reticulum aminopeptidase 1. Diabetes 69, 670\u2013680 (2020).","journal-title":"Diabetes"},{"key":"443_CR105","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1210\/en.2017-03273","volume":"159","author":"MR Marasco","year":"2018","unstructured":"Marasco, M. R. & Linnemann, A. K. \u03b2-Cell autophagy in diabetes pathogenesis. Endocrinology 159, 2127\u20132141 (2018).","journal-title":"Endocrinology"},{"key":"443_CR106","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/JME-15-0306","volume":"57","author":"K Meyerovich","year":"2016","unstructured":"Meyerovich, K., Ortis, F., Allagnat, F. & Cardozo, A. K. Endoplasmic reticulum stress and the unfolded protein response in pancreatic islet inflammation. J. Mol. Endocrinol. 57, R1\u2013R17 (2016).","journal-title":"J. Mol. Endocrinol."},{"key":"443_CR107","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1007\/s00125-013-3045-3","volume":"56","author":"J Storling","year":"2013","unstructured":"Storling, J. et al. Do post-translational beta cell protein modifications trigger type 1 diabetes? Diabetologia 56, 2347\u20132354 (2013).","journal-title":"Diabetologia"},{"key":"443_CR108","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.ebiom.2015.03.012","volume":"2","author":"L Marroqui","year":"2015","unstructured":"Marroqui, L. et al. Pancreatic \u03b1 cells are resistant to metabolic stress-induced apoptosis in type 2 diabetes. EBioMedicine 2, 378\u2013385 (2015).","journal-title":"EBioMedicine"},{"key":"443_CR109","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1074\/jbc.M110.162131","volume":"286","author":"F Moore","year":"2011","unstructured":"Moore, F. et al. STAT1 is a master regulator of pancreatic \u03b2-cell apoptosis and islet inflammation. J. Biol. Chem. 286, 929\u2013941 (2011).","journal-title":"J. Biol. Chem."},{"key":"443_CR110","doi-asserted-by":"publisher","first-page":"9947","DOI":"10.18632\/aging.102432","volume":"11","author":"N Li","year":"2019","unstructured":"Li, N. et al. Aging and stress induced \u03b2 cell senescence and its implication in diabetes development. Aging 11, 9947\u20139959 (2019).","journal-title":"Aging"},{"key":"443_CR111","doi-asserted-by":"publisher","first-page":"9601801","DOI":"10.1155\/2018\/9601801","volume":"2018","author":"J Rojas","year":"2018","unstructured":"Rojas, J. et al. Pancreatic beta cell death: novel potential mechanisms in diabetes therapy. J. Diabetes Res. 2018, 9601801 (2018).","journal-title":"J. Diabetes Res."},{"key":"443_CR112","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.cmet.2019.01.021","volume":"29","author":"PJ Thompson","year":"2019","unstructured":"Thompson, P. J. et al. Targeted elimination of senescent beta cells prevents type 1 diabetes. Cell Metab. 29, 1045\u20131060.e10 (2019).","journal-title":"Cell Metab."},{"key":"443_CR113","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/j.1365-2249.2009.04087.x","volume":"159","author":"BO Roep","year":"2010","unstructured":"Roep, B. O. et al. Islet inflammation and CXCL10 in recent-onset type 1 diabetes. Clin. Exp. Immunol. 159, 338\u2013343 (2010).","journal-title":"Clin. Exp. Immunol."},{"key":"443_CR114","doi-asserted-by":"publisher","first-page":"4185","DOI":"10.1074\/jbc.M116.745877","volume":"292","author":"P Bonvin","year":"2017","unstructured":"Bonvin, P. et al. Antibody neutralization of CXCL10 in vivo is dependent on binding to free and not endothelial-bound chemokine: implications for the design of a new generation of anti-chemokine therapeutic antibodies. J. Biol. Chem. 292, 4185\u20134197 (2017).","journal-title":"J. Biol. Chem."},{"key":"443_CR115","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/s41591-018-0089-4","volume":"24","author":"F Ovalle","year":"2018","unstructured":"Ovalle, F. et al. Verapamil and beta cell function in adults with recent-onset type 1 diabetes. Nat. Med. 24, 1108\u20131112 (2018).","journal-title":"Nat. Med."},{"key":"443_CR116","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s00125-013-3155-y","volume":"57","author":"L Krogvold","year":"2014","unstructured":"Krogvold, L. et al. Pancreatic biopsy by minimal tail resection in live adult patients at the onset of type 1 diabetes: experiences from the DiViD study. Diabetologia 57, 841\u2013843 (2014).","journal-title":"Diabetologia"},{"key":"443_CR117","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41586-018-0341-6","volume":"560","author":"X Wan","year":"2018","unstructured":"Wan, X. et al. Pancreatic islets communicate with lymphoid tissues via exocytosis of insulin peptides. Nature 560, 107\u2013111 (2018).","journal-title":"Nature"},{"key":"443_CR118","doi-asserted-by":"publisher","first-page":"E10418","DOI":"10.1073\/pnas.1713543114","volume":"114","author":"JA Carrero","year":"2017","unstructured":"Carrero, J. A. et al. Resident macrophages of pancreatic islets have a seminal role in the initiation of autoimmune diabetes of NOD mice. Proc. Natl Acad. Sci. USA 114, E10418\u2013E10427 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"443_CR119","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3109\/08916938909019963","volume":"3","author":"V Kolb-Bachofen","year":"1989","unstructured":"Kolb-Bachofen, V. & Kolb, H. A role for macrophages in the pathogenesis of type 1 diabetes. Autoimmunity 3, 145\u2013154 (1989).","journal-title":"Autoimmunity"},{"key":"443_CR120","first-page":"119","volume":"5","author":"E Gulden","year":"2014","unstructured":"Gulden, E. & Wen, L. Toll-like receptor activation in immunity vs. tolerance in autoimmune diabetes. Front. Immunol. 5, 119 (2014).","journal-title":"Front. Immunol."},{"issue":"Suppl. 1","key":"443_CR121","doi-asserted-by":"crossref","first-page":"41.13","DOI":"10.4049\/jimmunol.200.Supp.41.13","volume":"200","author":"JA Carrero","year":"2018","unstructured":"Carrero, J. A. et al. Depletion of islet resident macrophages protects mice from type 1 diabetes [abstract]. J. Immunol. 200 (Suppl. 1), 41.13 (2018).","journal-title":"J. Immunol."},{"key":"443_CR122","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/348639a0","volume":"348","author":"P Hutchings","year":"1990","unstructured":"Hutchings, P. et al. Transfer of diabetes in mice prevented by blockade of adhesion- promoting receptor on macrophages. Nature 348, 639\u2013642 (1990).","journal-title":"Nature"},{"key":"443_CR123","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11892-017-0915-y","volume":"17","author":"SC Kent","year":"2017","unstructured":"Kent, S. C., Mannering, S. I., Michels, A. W. & Babon, J. A. B. Deciphering the pathogenesis of human type 1 diabetes (T1D) by interrogating T cells from the \u201cscene of the crime\u201d. Curr. Diab Rep. 17, 95 (2017).","journal-title":"Curr. Diab Rep."},{"key":"443_CR124","doi-asserted-by":"publisher","first-page":"378","DOI":"10.2119\/molmed.2011.00021","volume":"17","author":"DP Christensen","year":"2011","unstructured":"Christensen, D. P. et al. Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus. Mol. Med. 17, 378\u2013390 (2011).","journal-title":"Mol. Med."},{"key":"443_CR125","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.biopha.2018.10.163","volume":"109","author":"HA Lee","year":"2019","unstructured":"Lee, H. A. et al. Histone deacetylase inhibitor MGCD0103 protects the pancreas from streptozotocin-induced oxidative stress and \u03b2-cell death. Biomed. Pharmacother. 109, 921\u2013929 (2019).","journal-title":"Biomed. Pharmacother."},{"key":"443_CR126","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s00125-016-3897-4","volume":"59","author":"J Rui","year":"2016","unstructured":"Rui, J. et al. Methylation of insulin DNA in response to proinflammatory cytokines during the progression of autoimmune diabetes in NOD mice. Diabetologia 59, 1021\u20131029 (2016).","journal-title":"Diabetologia"},{"key":"443_CR127","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1038\/s41588-019-0524-6","volume":"51","author":"M Ramos-Rodriguez","year":"2019","unstructured":"Ramos-Rodriguez, M. et al. The impact of proinflammatory cytokines on the \u03b2-cell regulatory landscape provides insights into the genetics of type 1 diabetes. Nat. Genet. 51, 1588\u20131595 (2019).","journal-title":"Nat. Genet."},{"key":"443_CR128","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1002\/pmic.201500333","volume":"16","author":"CW Liu","year":"2016","unstructured":"Liu, C. W., Atkinson, M. A. & Zhang, Q. Type 1 diabetes cadaveric human pancreata exhibit a unique exocrine tissue proteomic profile. Proteomics 16, 1432\u20131446 (2016).","journal-title":"Proteomics"},{"key":"443_CR129","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.ygeno.2013.12.007","volume":"103","author":"M Lopes","year":"2014","unstructured":"Lopes, M. et al. Temporal profiling of cytokine-induced genes in pancreatic \u03b2-cells by meta-analysis and network inference. Genomics 103, 264\u2013275 (2014).","journal-title":"Genomics"},{"key":"443_CR130","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.cmet.2018.07.007","volume":"28","author":"S Gonzalez-Duque","year":"2018","unstructured":"Gonzalez-Duque, S. et al. Conventional and neo-antigenic peptides presented by \u03b2 cells are targeted by circulating naive CD8+ T cells in type 1 diabetic and healthy donors. Cell Metab. 28, 946\u2013960.e6 (2018).","journal-title":"Cell Metab."},{"key":"443_CR131","doi-asserted-by":"publisher","first-page":"895","DOI":"10.2337\/diabetes.50.4.895","volume":"50","author":"J Diez","year":"2001","unstructured":"Diez, J. et al. Differential splicing of the IA-2 mRNA in pancreas and lymphoid organs as a permissive genetic mechanism for autoimmunity against the IA-2 type 1 diabetes autoantigen. Diabetes 50, 895\u2013900 (2001).","journal-title":"Diabetes"},{"key":"443_CR132","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02763-y","volume":"9","author":"B Raposo","year":"2018","unstructured":"Raposo, B. et al. T cells specific for post-translational modifications escape intrathymic tolerance induction. Nat. Commun. 9, 353 (2018).","journal-title":"Nat. Commun."},{"key":"443_CR133","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/cei.12775","volume":"185","author":"RJ McLaughlin","year":"2016","unstructured":"McLaughlin, R. J. et al. Human islets and dendritic cells generate post-translationally modified islet autoantigens. Clin. Exp. Immunol. 185, 133\u2013140 (2016).","journal-title":"Clin. Exp. Immunol."},{"key":"443_CR134","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1126\/science.aad2791","volume":"351","author":"T Delong","year":"2016","unstructured":"Delong, T. et al. Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion. Science 351, 711\u2013714 (2016).","journal-title":"Science"},{"issue":"Suppl. 2","key":"443_CR135","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/dom.13387","volume":"20","author":"S Thomaidou","year":"2018","unstructured":"Thomaidou, S., Zaldumbide, A. & Roep, B. O. Islet stress, degradation and autoimmunity. Diabetes Obes. Metab. 20 (Suppl. 2), 88\u201394 (2018).","journal-title":"Diabetes Obes. Metab."},{"key":"443_CR136","doi-asserted-by":"publisher","first-page":"335","DOI":"10.2337\/db09-1767","volume":"59","author":"JC Hutton","year":"2010","unstructured":"Hutton, J. C. & Davidson, H. W. Cytokine-induced dicing and splicing in the \u03b2-cell and the immune response in type 1 diabetes. Diabetes 59, 335\u2013336 (2010).","journal-title":"Diabetes"},{"issue":"Suppl. 2","key":"443_CR137","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/dom.13388","volume":"20","author":"MI Alvelos","year":"2018","unstructured":"Alvelos, M. I., Juan-Mateu, J., Colli, M. L., Turatsinze, J. V. & Eizirik, D. L. When one becomes many\u2013alternative splicing in \u03b2-cell function and failure. Diabetes Obes. Metab. 20 (Suppl. 2), 77\u201387 (2018).","journal-title":"Diabetes Obes. Metab."},{"key":"443_CR138","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3389\/fcell.2015.00067","volume":"3","author":"ML Marre","year":"2015","unstructured":"Marre, M. L., James, E. A. & Piganelli, J. D. \u03b2 cell ER stress and the implications for immunogenicity in type 1 diabetes. Front. Cell Dev. Biol. 3, 67 (2015).","journal-title":"Front. Cell Dev. Biol."},{"key":"443_CR139","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06405-9","volume":"9","author":"M Zhang","year":"2018","unstructured":"Zhang, M. et al. RNA editing derived epitopes function as cancer antigens to elicit immune responses. Nat. Commun. 9, 3919 (2018).","journal-title":"Nat. Commun."},{"key":"443_CR140","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.celrep.2018.03.036","volume":"23","author":"SH Roth","year":"2018","unstructured":"Roth, S. H. et al. Increased RNA editing may provide a source for autoantigens in systemic lupus erythematosus. Cell Rep. 23, 50\u201357 (2018).","journal-title":"Cell Rep."},{"key":"443_CR141","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1007\/s00125-018-4731-y","volume":"61","author":"NG Morgan","year":"2018","unstructured":"Morgan, N. G. & Richardson, S. J. Fifty years of pancreatic islet pathology in human type 1 diabetes: insights gained and progress made. Diabetologia 61, 2499\u20132506 (2018).","journal-title":"Diabetologia"},{"key":"443_CR142","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00125-019-4822-4","volume":"62","author":"RA Oram","year":"2019","unstructured":"Oram, R. A., Sims, E. K. & Evans-Molina, C. Beta cells in type 1 diabetes: mass and function; sleeping or dead? Diabetologia 62, 567\u2013577 (2019).","journal-title":"Diabetologia"},{"key":"443_CR143","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.cels.2016.09.002","volume":"3","author":"MJ Muraro","year":"2016","unstructured":"Muraro, M. J. et al. A single-cell transcriptome atlas of the human pancreas. Cell Syst. 3, 385\u2013394.e3 (2016).","journal-title":"Cell Syst."},{"key":"443_CR144","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.cmet.2019.01.003","volume":"29","author":"YJ Wang","year":"2019","unstructured":"Wang, Y. J. et al. Multiplexed in situ imaging mass cytometry analysis of the human endocrine pancreas and immune system in type 1 diabetes. Cell Metab. 29, 769\u2013783.e4 (2019).","journal-title":"Cell Metab."},{"key":"443_CR145","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.cmet.2018.11.014","volume":"29","author":"N Damond","year":"2019","unstructured":"Damond, N. et al. A map of human type 1 diabetes progression by imaging mass cytometry. Cell Metab. 29, 755\u2013768.e5 (2019).","journal-title":"Cell Metab."},{"issue":"Suppl. 1","key":"443_CR146","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/dom.13019","volume":"19","author":"D Avrahami","year":"2017","unstructured":"Avrahami, D. et al. \u03b2-Cells are not uniform after all\u2013novel insights into molecular heterogeneity of insulin-secreting cells. Diabetes Obes. Metab. 19 (Suppl. 1), 147\u2013152 (2017).","journal-title":"Diabetes Obes. Metab."},{"key":"443_CR147","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1038\/s41591-018-0236-y","volume":"24","author":"AM Falcao","year":"2018","unstructured":"Falcao, A. M. et al. Disease-specific oligodendrocyte lineage cells arise in multiple sclerosis. Nat. Med. 24, 1837\u20131844 (2018).","journal-title":"Nat. Med."},{"key":"443_CR148","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s11892-019-1192-8","volume":"19","author":"M Blanter","year":"2019","unstructured":"Blanter, M., Sork, H., Tuomela, S. & Flodstr\u00f6m-Tullberg, M. Genetic and environmental interaction in type 1 diabetes: a relationship between genetic risk alleles and molecular traits of enterovirus infection? Curr. Diab. Rep. 19, 82 (2019).","journal-title":"Curr. Diab. Rep."},{"key":"443_CR149","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1212\/WNL.0000000000003794","volume":"88","author":"P Maddison","year":"2017","unstructured":"Maddison, P., Gozzard, P., Grainge, M. J. & Lang, B. Long-term survival in paraneoplastic Lambert-Eaton myasthenic syndrome. Neurology 88, 1334\u20131339 (2017).","journal-title":"Neurology"},{"key":"443_CR150","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1200\/JCO.2010.32.0440","volume":"29","author":"MJ Titulaer","year":"2011","unstructured":"Titulaer, M. J. et al. Clinical Dutch-English Lambert-Eaton myasthenic syndrome (LEMS) tumor association prediction score accurately predicts small-cell lung cancer in the LEMS. J. Clin. Oncol. 29, 902\u2013908 (2011).","journal-title":"J. Clin. Oncol."},{"key":"443_CR151","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jneuroim.2004.10.018","volume":"159","author":"PW Wirtz","year":"2005","unstructured":"Wirtz, P. W. et al. HLA and smoking in prediction and prognosis of small cell lung cancer in autoimmune Lambert-Eaton myasthenic syndrome. J. Neuroimmunol. 159, 230\u2013237 (2005).","journal-title":"J. Neuroimmunol."},{"key":"443_CR152","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nature13988","volume":"515","author":"MM Gubin","year":"2014","unstructured":"Gubin, M. M. et al. Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens. Nature 515, 577\u2013581 (2014).","journal-title":"Nature"},{"key":"443_CR153","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.ebiom.2018.09.040","volume":"36","author":"ML Colli","year":"2018","unstructured":"Colli, M. L. et al. PDL1 is expressed in the islets of people with type 1 diabetes and is up-regulated by interferons-\u03b1 and-\u03b3 via IRF1 induction. EBioMedicine 36, 367\u2013375 (2018).","journal-title":"EBioMedicine"},{"key":"443_CR154","doi-asserted-by":"publisher","first-page":"72","DOI":"10.2337\/db06-0617","volume":"56","author":"SA Sarkar","year":"2007","unstructured":"Sarkar, S. A. et al. Induction of indoleamine 2,3-dioxygenase by interferon-\u03b3 in human islets. Diabetes 56, 72\u201379 (2007).","journal-title":"Diabetes"},{"key":"443_CR155","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.2337\/db17-1281","volume":"67","author":"F Anquetil","year":"2018","unstructured":"Anquetil, F. et al. Loss of IDO1 expression from human pancreatic \u03b2-cells precedes their destruction during the development of type 1 diabetes. Diabetes 67, 1858\u20131866 (2018).","journal-title":"Diabetes"},{"key":"443_CR156","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.2337\/db07-1817","volume":"57","author":"E Akirav","year":"2008","unstructured":"Akirav, E., Kushner, J. A. & Herold, K. C. \u03b2-Cell mass and type 1 diabetes: going, going, gone? Diabetes 57, 2883\u20132888 (2008).","journal-title":"Diabetes"},{"key":"443_CR157","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.molmet.2017.06.019","volume":"6","author":"C Chen","year":"2017","unstructured":"Chen, C., Cohrs, C. M., Stertmann, J., Bozsak, R. & Speier, S. Human beta cell mass and function in diabetes: recent advances in knowledge and technologies to understand disease pathogenesis. Mol. Metab. 6, 943\u2013957 (2017).","journal-title":"Mol. Metab."},{"key":"443_CR158","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11892-019-1194-6","volume":"19","author":"ASM Moin","year":"2019","unstructured":"Moin, A. S. M. & Butler, A. E. Alterations in beta cell identity in type 1 and type 2 diabetes. Curr. Diab Rep. 19, 83 (2019).","journal-title":"Curr. Diab Rep."},{"key":"443_CR159","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1210\/jc.2016-1350","volume":"101","author":"AS Md Moin","year":"2016","unstructured":"Md Moin, A. S. et al. Increased hormone-negative endocrine cells in the pancreas in type 1 diabetes. J. Clin. Endocrinol. Metab. 101, 3487\u20133496 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"443_CR160","doi-asserted-by":"publisher","first-page":"R57","DOI":"10.1530\/JME-17-0138","volume":"60","author":"HC Denroche","year":"2018","unstructured":"Denroche, H. C. & Verchere, C. B. IAPP and type 1 diabetes: implications for immunity, metabolism and islet transplants. J. Mol. Endocrinol. 60, R57\u2013R75 (2018).","journal-title":"J. Mol. Endocrinol."},{"key":"443_CR161","doi-asserted-by":"publisher","first-page":"eaaf7779","DOI":"10.1126\/scitranslmed.aaf7779","volume":"9","author":"M Alhadj Ali","year":"2017","unstructured":"Alhadj Ali, M. et al. Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes. Sci. Transl Med. 9, eaaf7779 (2017).","journal-title":"Sci. Transl Med."},{"key":"443_CR162","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/S2213-8587(20)30104-2","volume":"8","author":"T Nikolic","year":"2020","unstructured":"Nikolic, T. et al. Safety and feasibility of intradermal injection with tolerogenic dendritic cells pulsed with proinsulin peptide\u2013for type 1 diabetes. Lancet Diabetes Endocrinol. 8, 470\u2013472 (2020).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"443_CR163","doi-asserted-by":"publisher","first-page":"484","DOI":"10.2337\/diabetes.48.3.484","volume":"48","author":"BO Roep","year":"1999","unstructured":"Roep, B. O. et al. Auto- and alloimmune reactivity to human islet allografts transplanted to insulin-dependent diabetes mellitus patients. Diabetes 48, 484\u2013490 (1999).","journal-title":"Diabetes"},{"key":"443_CR164","doi-asserted-by":"publisher","first-page":"947","DOI":"10.2337\/db09-0498","volume":"59","author":"F Vendrame","year":"2010","unstructured":"Vendrame, F. et al. Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells. Diabetes 59, 947\u2013957 (2010).","journal-title":"Diabetes"},{"key":"443_CR165","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1172\/JCI19585","volume":"113","author":"S Arif","year":"2004","unstructured":"Arif, S. et al. Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. J. Clin. Invest. 113, 451\u2013463 (2004).","journal-title":"J. Clin. Invest."},{"key":"443_CR166","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1056\/NEJMoa043980","volume":"352","author":"B Keymeulen","year":"2005","unstructured":"Keymeulen, B. et al. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N. Engl. J. Med. 352, 2598\u20132608 (2005).","journal-title":"N. Engl. J. Med."},{"key":"443_CR167","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1056\/NEJMoa012864","volume":"346","author":"KC Herold","year":"2002","unstructured":"Herold, K. C. et al. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes. N. Engl. J. Med. 346, 1692\u20131698 (2002).","journal-title":"N. Engl. J. Med."},{"key":"443_CR168","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1001\/jama.297.14.1568","volume":"297","author":"JC Voltarelli","year":"2007","unstructured":"Voltarelli, J. C. et al. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 297, 1568\u20131576 (2007).","journal-title":"JAMA"},{"key":"443_CR169","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/S0140-6736(11)60886-6","volume":"378","author":"T Orban","year":"2011","unstructured":"Orban, T. et al. Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial. Lancet 378, 412\u2013419 (2011).","journal-title":"Lancet"},{"key":"443_CR170","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S2213-8587(13)70111-6","volume":"1","author":"MR Rigby","year":"2013","unstructured":"Rigby, M. R. et al. Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Diabetes Endocrinol. 1, 284\u2013294 (2013).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"443_CR171","doi-asserted-by":"publisher","first-page":"7350","DOI":"10.4049\/jimmunol.181.10.7350","volume":"181","author":"A Schneider","year":"2008","unstructured":"Schneider, A. et al. The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells. J. Immunol. 181, 7350\u20137355 (2008).","journal-title":"J. Immunol."},{"key":"443_CR172","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1126\/science.1075958","volume":"298","author":"MS Anderson","year":"2002","unstructured":"Anderson, M. S. et al. Projection of an immunological self shadow within the thymus by the AIRE protein. Science 298, 1395\u20131401 (2002).","journal-title":"Science"},{"key":"443_CR173","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/83707","volume":"27","author":"RS Wildin","year":"2001","unstructured":"Wildin, R. S. et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 27, 18\u201320 (2001).","journal-title":"Nat. Genet."},{"key":"443_CR174","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1172\/JCI119423","volume":"99","author":"J Endl","year":"1997","unstructured":"Endl, J. et al. Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients. J. Clin. Invest. 99, 2405\u20132415 (1997).","journal-title":"J. Clin. Invest."},{"key":"443_CR175","doi-asserted-by":"publisher","first-page":"191ra82","DOI":"10.1126\/scitranslmed.3006103","volume":"5","author":"BO Roep","year":"2013","unstructured":"Roep, B. O. et al. Plasmid-encoded proinsulin preserves C-peptide while specifically reducing proinsulin-specific CD8+ T cells in type 1 diabetes. Sci. Transl Med. 5, 191ra82 (2013).","journal-title":"Sci. Transl Med."},{"key":"443_CR176","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/j.1365-2249.2008.03656.x","volume":"152","author":"VA Huurman","year":"2008","unstructured":"Huurman, V. A. et al. Immunological efficacy of heat shock protein 60 peptide DiaPep277 therapy in clinical type I diabetes. Clin. Exp. Immunol. 152, 488\u2013497 (2008).","journal-title":"Clin. Exp. Immunol."},{"key":"443_CR177","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2337\/db12-1214","volume":"63","author":"M van Lummel","year":"2014","unstructured":"van Lummel, M. et al. Posttranslational modification of HLA-DQ binding islet autoantigens in type 1 diabetes. Diabetes 63, 237\u2013247 (2014).","journal-title":"Diabetes"},{"key":"443_CR178","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/gene.2012.38","volume":"14","author":"VM de Jong","year":"2013","unstructured":"de Jong, V. M. et al. Post-transcriptional control of candidate risk genes for type 1 diabetes by rare genetic variants. Genes Immun. 14, 58\u201361 (2013).","journal-title":"Genes Immun."}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41574-020-00443-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-020-00443-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-020-00443-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T18:11:27Z","timestamp":1733940687000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41574-020-00443-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,8]]},"references-count":178,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["443"],"URL":"https:\/\/doi.org\/10.1038\/s41574-020-00443-4","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,8]]},"assertion":[{"value":"4 November 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}